期刊文献+

内吗啡肽-1类似物HDAPC聚氰基丙烯酸正丁酯纳米粒的镇痛活性 被引量:2

Analgesic activity of polybutylcyanoacrylate nanoparticles of HDAPC,an analog of Endomorphin-1
下载PDF
导出
摘要 采用界面聚合法制备聚氰基丙烯酸正丁酯纳米粒,吸附药物内吗啡肽-1类似物HDAPC后孵育包衣聚山梨酯80。采用透射电镜观测纳米粒粒径为(150.00±9.75)nm,高效液相色谱法测定包封率为(87.64±3.02)%。静脉注射后小鼠甩尾镇痛法检测镇痛效果,包衣聚山梨酯80的HDAPC-NP-P80比HDAPC及未包衣聚山梨酯80的HDAPC-NP镇痛效果更有效,最大镇痛时间延后在12.5min,最大可能效应百分数达100,剂量减半在同样时间点最大可能效应百分数也能达到76.64。结果提示纳米粒是一种有效的将肽类药物传递进入大脑的载体,空白纳米粒吸附药物后,必须包衣聚山梨酯80才有镇痛增强的效果。 HDAPC (Tyr-D-Ala-Trp-p-Cl-Phe-OH) nanopaticles were prepared by interfacial polymerization method. The peptide was adsorbed onto the surface of PBCA nanoparticles and coated with polysorbate 80. The transmission electron microscope showed that the particle size of nanoparticles was (150.00±9.75) nm, and the HPLC method measured that the entrapment efficiency was (87.64±3.02)%. After intravenous injection of this formulation to mice, the central analgesia was measured by tai flick test, which showed that HDAPC-NP coated with P80 displayed more effective analgesic effect than HDAPC, or uncoated HDAPC-NP. HDAPC-NP-P80 had a maximum analgesic effect of 100(%MPE) at 12.5 min, and the analgesic effect was 76.64(%MPE) at half of the dose at the same time. The results suggest that nanoparticle is an effective drug vector to carry peptide into brain. The drug was adsorbed onto the surface of nanoparticles, and then the coated with P80 is necessarily.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第21期4022-4024,共3页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 甘肃省自然科学基金资助项目(0803RJZA079)~~
  • 相关文献

参考文献8

  • 1Liu HM,Liu XE Yao J L,et al.Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1.J Pharmacol Exp Ther.2006;319(1):308-316.
  • 2Lockman PR,Mumper RJ.Khan MA,et al.Nanoparticle technology for drug delivery across the blood-brain barrier.Drug Dev Ind Pharm.2002;28(1):1-3.
  • 3Schroeder U,Sommerfeld P,Sabel BA.Efficacy of oral dalargin-loaded nanopartide delivery across the blood-brain barrier.Peptides.1998;19(4):777-780.
  • 4Beck P,Kreuter J,Reszka R,et al.Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models.J Microencapsul.1993;10(1):101-114.
  • 5孟然,周晋,王德生,李国忠,戚基萍,杨宝峰.甘露醇暂时渗透性开放血脑屏障的研究[J].中风与神经疾病杂志,2003,20(4):350-352. 被引量:23
  • 6Kreuter J,Alyautdin RN.Kharkevich DA.et al.Passage of peptides through the blood-brain barrier with colloidal polymer perticles (nanoparticles).Brain Res.1995;674(1):171-174.
  • 7Wilson B,Samanta MK,Santhi K,et al.Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate)nanoparticles.Eur J Pharnl Biopharm,2008;70(1):75-84.
  • 8Gessner A,Olbrich C,Schroder W,et al.The role of plasma proteins in brain targeting:species dependent protein adsorption pattems on brain-specific lipid drug conjugate(LDC)nanopartides.Int J Pharm.2001;214(1-2):87-91.

二级参考文献4

  • 1[1]Bhattacharjee AK, Nagashina T, Kondoh T,et al. Quantification of early blood brain barrier disruption by in situ brain perfusion technique[J]. Brain Res Protoc ,2001,8(2):126-131.
  • 2[2]Pan GY, Liu XD, Liu GQ. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats[J]. Acta Pharmacol Sin,2000,21(7):613-616.
  • 3[3]Bhattacharjee AK, Nagashina T, Kondoh T, et al. The effects of the Na+/Ca++exchange blocker on osmotic blood-brain barrier disruption[J]. Brain Res, 2001,900(2):157-162.
  • 4[4]Rapoport SI. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy [J]. Brain Res, 2001,10(10):1809-1818.

共引文献22

同被引文献86

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部